The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak
暂无分享,去创建一个
Roberto Cesareo | Carlo Vancheri | Massimiliano Fabbiani | Sebastiano Emanuele Torrisi | Lorenzo Malatino | C. Vancheri | S. Di Bella | R. Luzzati | D. Sambataro | G. Sambataro | A. Palermo | R. Cesareo | N. Del Papa | L. Malatino | M. Fabbiani | E. Roman-Pognuz | Mauro Giuffrè | Stefano Di Bella | Roberto Luzzati | V. Zuccaro | Lorenzo Cavagna | N. Crimi | F. Montagnani | Francesca Montagnani | S. Torrisi | Gianluca Sambataro | M. Colaci | Verena Zerbato | Andrea Palermo | Michele Colaci | M. Giuffré | Nunzio Crimi | Domenico Sambataro | Giovanna Vignigni | Nicoletta Del Papa | Francesca Pignataro | Erik Roman-Pognuz | Chiara Cassol | Valentina Zuccaro | Cristina Maurel | L. Cavagna | Verena Zerbato | C. Maurel | F. Pignataro | Giovanna Vignigni | C. Cassol | S. di Bella
[1] Hongming Miao,et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal transduction and targeted therapy.
[2] Jun Zhang,et al. Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression , 2020, International Journal of Infectious Diseases.
[3] L. Boon,et al. Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. , 2010, Blood.
[4] Chi-kong Li,et al. Thrombocytopenia in patients with severe acute respiratory syndrome (review) , 2005, Hematology.
[5] Michel Theron,et al. An interferon‐γ‐related cytokine storm in SARS patients† , 2004, Journal of medical virology.
[6] R. Woods,et al. Neutrophil extracellular traps in COVID-19. , 2020, JCI insight.
[7] Z. Fayad,et al. Artificial intelligence–enabled rapid diagnosis of patients with COVID-19 , 2020, Nature Medicine.
[8] T. Güngör,et al. Two new inflammatory markers associated with Disease Activity Score‐28 in patients with rheumatoid arthritis: neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio , 2015, International journal of rheumatic diseases.
[9] S. Lofgren,et al. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 , 2020, Annals of Internal Medicine.
[10] Jian-Ping Liu,et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients , 2020, International Immunopharmacology.
[11] G. Zini,et al. Morphological anomalies of circulating blood cells in COVID‐19 , 2020, American journal of hematology.
[12] Depei Wu,et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China , 2020, Thrombosis Research.
[13] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[14] A. Pulvirenti,et al. Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[15] H. Ullum,et al. The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis , 2018, Multiple sclerosis journal - experimental, translational and clinical.
[16] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[17] Lei Liu,et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections , 2020, medRxiv.
[18] G. Bedogni,et al. Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis. , 2019, Annals of hepatology.
[19] W. Self,et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. , 2015, The New England journal of medicine.
[20] R. Caporali,et al. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? , 2020, Autoimmunity Reviews.
[21] W. Ko,et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths , 2020, Journal of Microbiology, Immunology and Infection.
[22] A. Ateş,et al. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis , 2019, Clinical Rheumatology.
[23] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[24] A. Addeo,et al. Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy , 2020, Clinical and Translational Oncology.
[25] Xiaohu Zheng,et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients , 2020, National science review.
[26] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[27] Michael J Pencina,et al. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models , 2012, Statistics in medicine.
[28] Wei Zhang,et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.
[29] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.
[30] Steven Woloshin,et al. False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications. , 2020, The New England journal of medicine.
[31] M. Nolte,et al. Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output , 2016, Front. Immunol..
[32] Peter Rogerson,et al. Statistical methods for geography , 2001 .
[33] T. van der Poll,et al. The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia , 2012, PloS one.
[34] A. Pulvirenti,et al. Neutrophil‐To‐Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community‐Acquired Pneumonia , 2017, Journal of the American Geriatrics Society.
[35] P. Winichakoon,et al. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19 , 2020, Journal of Clinical Microbiology.
[36] Binqing Fu,et al. Why tocilizumab could be an effective treatment for severe COVID-19? , 2020, Journal of Translational Medicine.